Navigation Links
Dementia Rates Escalate as Brain Capacity Diminishes with Age

The latest report entitled Keeping Dementia Front of Mind highlights the prevalence of the brain condition for governments when making policy and budget decisions. Research has shown brainpower peaks in the mid-twenties and then declines and we lose up to 50% of our brain’s capacity by our mid-fifties. Quincy Bioscience is developing a new approach toward this growing problem.

Madison, Wis (Vocus) February 9, 2010 -- The latest report entitled “Keeping Dementia Front of Mind” highlights the prevalence of the brain condition for governments when making policy and budget decisions. Research has shown brainpower peaks in the mid-twenties and then declines and we lose up to 50% of our brain’s capacity by our mid-fifties. Quincy Bioscience is developing a new approach toward this growing problem.

There are 77 million Baby Boomers in the United States are rapidly growing. A discussion about dementia is uncomfortable, but will be impossible to avoid for many. “People are afraid of the unknown and scared of the memory loss they are seeing in aging relatives,” says Quincy Bioscience president Mark Underwood. “However, there is hope coming around the corner.”

Without a breakthrough in the fight against dementia, this number could jump to as many as 84 million who have age-related memory loss by the year 2040.    Dementia is a subject avoided by most. Just the thought of memory loss - in a loved one, friend, co-worker or, worse yet, ourselves -- makes us terribly uncomfortable. Unless we are confronted directly with dementia, we prefer to think of it as "someone else's problem."
“Aging is scary and the solutions we have been researching can give people some peace. We now know why the brain loses its “horsepower” by age 55, and we have found a solution in nature to replace this key component.” Underwood continues, referring to his company’s discovery.

The hope lies within some technology developed at Quincy Bioscience, a biotechnology company headquartered in Madison, Wisconsin. They have developed a technology to help keep brain cells alive longer and hopefully to fight the ravages of dementia. “We have demonstrated keeping brain cells alive in animal tissues and these techniques crossover to help with the human mind also.” The key component was isolated in a jellyfish, a protein, a simple component that allows jellyfish to sting, but people not to be “stung” by the age-related changes that lead to dementia.

Underwood states, “Our population is "graying" and our citizens are living much longer than any previous generation. The fastest growing segment of our population is the over 80 age group, and the odds of becoming demented for the very elderly are much higher. So we have to act now, to protect our nation’s best and most precious resources, our brains.”

Quincy Bioscience ( is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products. The company’s first product, Prevagen (, was launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging.

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

**Health and dementia statistics are from the Alzheimer's Association, the National Center for Health Statistics, the Center for Disease Control, and Alzheimer's Australia.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Early Weight Loss in Women Linked to Dementia
2. Smokers More Likely to Develop Dementia
3. PA Soldiers and Sailors Home Dedicates 32-Bed Dementia/Alzheimers Unit
4. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
5. Antidepressant as Good as Antipsychotics for Dementia
6. Falling Platelet Counts May Signal HIV-Linked Dementia
7. Tooth loss, dementia may be linked, JADA study suggests
8. Building efficient, effective, locally sensitive solutions for dementia care
9. Editorial says primary care system must change how it approaches dementia
10. Tooth Troubles Could Raise Dementia Risk
11. Dementia in More Educated Hits Later But Harder
Post Your Comments:
Related Image:
Dementia Rates Escalate as Brain Capacity Diminishes with Age
(Date:10/13/2015)... ... October 13, 2015 , ... ... IBM software products, introduced a new company, RightSensor™ LLC, an Internet of Things ... capability. RightSensor™ provides a fully-managed approach for customers requiring sensor hardware for ...
(Date:10/13/2015)... ... October 13, 2015 , ... e-con Systems Inc., a leading embedded ... See3CAM_CU40, the industry’s first RGB-IR pixel format camera with a USB 3.0 interface ... e-con’s See3CAM family of UVC USB 3.0 cameras, is based on the 1/3-inch OV4682 ...
(Date:10/13/2015)... ... ... Protein is essential to good health. You need it to make the bricks ... does the average man need in order to stay healthy? , The answer ... Harvard Men's Health Watch . Most Americans get about 15% of their calories ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... in McHenry County, Illinois with more than 59,000 emergency department visits per year, ... system (EDIS) from T-System, to help improve clinical, operational and financial outcomes. ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... World ... Driveway Snow Blanket, a snow melting invention that helps people in clearing snow away ... and will continue to grow at 3.8% per year," says Scott Cooper, CEO and ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... N.C. , Oct. 13, 2015  Yesterday Congresswoman ... Influenza Vaccines Holly Springs manufacturing site located in ... 2014, the facility has produced Flucelvax ® (Influenza ... the potential for faster start-up and is not reliant ... CSL Limited acquired the influenza vaccines business of Novartis ...
(Date:10/12/2015)... 12, 2015 Given the intricacy of ... challenging to deliver an ophthalmic drug effectively to a specific ... successful ocular drug delivery. These include dilution of a drug ... of conjunctiva and drug permeation issues with respect to the ... topical eye drops, is lost due to the aforementioned barriers. ...
(Date:10/12/2015)... CRANBURY, N.J. , Oct. 12, 2015 /PRNewswire/ ... that a securities fraud class action complaint was ... of New Jersey.  The complaint alleges that officers and ... Securities Exchange Act of 1934 between September 15, 2015 ... misleading statements about Amicus Therapeutics, business prospects.  Amicus is ...
Breaking Medicine Technology: